bemiparin

Trade name: Ivor

Small moleculeexperimental

Bemiparin is an antithrombotic and belongs to the group of low molecular weight heparins (LMWH). — Wikipedia

Clinical trial activity

5 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Mar 1, 2009 (NCT00863577)

Timeline

2000s

  1. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • bemiparin
  • bemiparin
  • bemiparin
  • bemiparin
  • bemiparin
  • bemiparin
  • bemiparin sodium
  • bemiparin sodium
  • bemiparin sodium
  • zibor

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05569681N/ADec 2, 2022Hawler Medical University, Kurdistan Board for Medical Specialist
NCT04604327Phase 3Oct 26, 2020Clinica Universidad de Navarra, University of Navarra
NCT04420299Phase 2Jun 4, 2020Fundación de investigación HM, GMP BIO Co., LTD., Syntax for Science
NCT03601338Early Phase 1 (Phase 1)Aug 1, 2015HAWLER Maternity Hospital, Hawler Medical University, Kurdistan Board for Medical Specialist
NCT00863577Phase 1Mar 1, 2009Rovi Pharmaceuticals Laboratories
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Hawler Medical UniversityAcademic/Hospital2222015
Kurdistan Board for Medical SpecialistAcademic/Hospital2022015
Clinica Universidad de NavarraAcademic/Hospital1112020
Fundación de investigación HMAcademic/Hospital1112020
GMP BIO Co., LTD.For profit1012020
HAWLER Maternity HospitalAcademic/Hospital1012015
Rovi Pharmaceuticals LaboratoriesFor profit1112009
Syntax for ScienceFor profit1012020
University of NavarraAcademic/Hospital1012020
9 organizations
Page 1 / 1